Pages that link to "Q38173683"
Jump to navigation
Jump to search
The following pages link to Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation (Q38173683):
Displaying 50 items.
- Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society (Q27347760) (← links)
- Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence (Q30250107) (← links)
- Intensified surveillance for early detection of breast cancer in high-risk patients (Q30392157) (← links)
- Mammography Decision Aid Reduces Decisional Conflict for Women in Their Forties Considering Screening (Q30690284) (← links)
- Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data (Q31036427) (← links)
- Cancer screening and genetics: a tale of two paradigms (Q33717364) (← links)
- Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect (Q33727903) (← links)
- Validation of a scale for assessing attitudes towards outcomes of genetic cancer testing among primary care providers and breast specialists (Q33751777) (← links)
- An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers (Q33901361) (← links)
- The "right not to know" in the genomic era: time to break from tradition? (Q34087461) (← links)
- The role of testing for BRCA1 and BRCA2 mutations in cancer prevention (Q34216381) (← links)
- The structural basis for cancer treatment decisions (Q34365654) (← links)
- Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents (Q34483451) (← links)
- Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing (Q34994574) (← links)
- Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial (Q35102571) (← links)
- Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers (Q35782790) (← links)
- Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women. (Q35922603) (← links)
- Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome (Q35998356) (← links)
- Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand (Q36205603) (← links)
- Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda (Q36229139) (← links)
- Preferences for the provision of whole genome sequencing services among young adults (Q36320065) (← links)
- Identifying post-menopausal women at elevated risk for epithelial ovarian cancer (Q36331643) (← links)
- A high frequency of BRCA mutations in young black women with breast cancer residing in Florida (Q36338690) (← links)
- Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells (Q36377493) (← links)
- Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations (Q36541027) (← links)
- Metastasis of Pregnancy-Associated Breast Cancer (Suspected to Be Hereditary Breast and Ovarian Cancer) to the Brain, Diagnosed at 18 Weeks' Gestation: A Case Report and Review of the Literature (Q36615358) (← links)
- High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling (Q36906183) (← links)
- Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing (Q37055268) (← links)
- Community-Based Family Health History Education: The Role of State Health Agencies in Engaging Medically Underserved Populations in Understanding Genomics and Risk of Chronic Disease (Q37069575) (← links)
- Counsellee's experience of cancer genetic counselling with pedigrees that automatically incorporate genealogical and cancer database information. (Q37124135) (← links)
- Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up (Q37234775) (← links)
- Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer (Q37234825) (← links)
- Use of BRCA Mutation Test in the U.S., 2004-2014. (Q38371909) (← links)
- Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom (Q38619184) (← links)
- Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery (Q38732720) (← links)
- Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors (Q38759417) (← links)
- The future of clinical cancer genomics (Q38789283) (← links)
- Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review (Q38807460) (← links)
- Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation (Q38851169) (← links)
- Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population? (Q38868393) (← links)
- A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital (Q38942684) (← links)
- The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients (Q39190175) (← links)
- Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. (Q39263736) (← links)
- Managing hereditary breast cancer risk in women with and without ovarian cancer (Q39270600) (← links)
- Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer (Q39718281) (← links)
- BRCA population screening for predicting breast cancer: for or against? (Q41050195) (← links)
- Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study (Q42260587) (← links)
- The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan (Q44039104) (← links)
- Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history (Q44717730) (← links)
- High-Risk Palliative Care Patients' Knowledge and Attitudes about Hereditary Cancer Testing and DNA Banking (Q45074754) (← links)